Investigator/ Infectious Disease Division
Dr. Timothy Endy is an international expert in the field of dengue, dengue hemorrhagic fever, and emerging viral pathogens. Dr. Endy has conducted research in the field of virology, developed vaccine-field and epidemiological study sites in Southeast and Central Asia, and conducted phase I and II clinical vaccine trials. Currently, Dr. Endy is the Principal Investigator (PI) for the US Army’s Dengue Human Infection Model (DHIM), which is being developed at SUNY Upstate.
He is also the co-PI for the clinical development of a heroin vaccine.
A Board Certified physician in the subspecialty of Infectious Diseases and Internal Medicine, he received a BS from Pennsylvania State University in University Park, PA; completed his Master’s of Public Health in Epidemiology from the University of Michigan’s School of Public Health in Ann Arbor, MI; and obtained his medical degree from the F. Edward Herbert School of Medicine at the Uniformed Services University in Bethesda, MD. Following this, he completed his residency and fellowship at the Walter Reed Army Medical Center in Washington, D.C. Dr. Endy served with distinction in the United States Army for 24 years and retired as a Colonel in 2006.
Dr. Endy is active in the development and management of research programs that are product-oriented towards developing vaccines, and diagnostics that meet FDA regulatory requirements. He is an NIH-funded researcher, conducting studies on dengue in Thailand. In addition, Dr. Endy is an active reviewer for peer reviewed journals, a subject matter expert on dengue and dengue vaccine development for industry partners, and has published over 120 manuscripts and book chapters.